Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Invasive ductal breast carcinoma
ADR ID BADD_A09192
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.10      Breast neoplasms malignant and unspecified (incl nipple)
16.10.01      Breast and nipple neoplasms malignant
16.10.01.013      Invasive ductal breast carcinoma
21      Reproductive system and breast disorders
21.05      Breast disorders
21.05.01      Benign and malignant breast neoplasms
21.05.01.021      Invasive ductal breast carcinoma
Description Not Available
MedDRA Code 10073095
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Breast ductal cancer infiltrating | Breast ductal cancer invasive | Ductal breast carcinoma stage II | Ductal breast carcinoma stage III | Ductal breast carcinoma stage IV | Infiltrating ductal breast cancer | Invasive ductal breast cancer | Breast ductal carcinoma | Invasive ductal breast carcinoma | Mixed ductal lobular breast carcinoma | Mixed ductal lobular breast carcinoma infiltrating
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00066Alendronic acid0.000707%
BADD_D00195Azathioprine0.000375%
BADD_D00511Clozapine--
BADD_D00528Conjugated estrogens0.002074%
BADD_D00680Dimethyl fumarate0.027505%
BADD_D00736Dutasteride0.000272%
BADD_D00809Escitalopram0.000142%
BADD_D00852Etonogestrel0.001650%
BADD_D00898Finasteride0.000214%
BADD_D01136Imatinib0.002131%
BADD_D01252Leflunomide0.002066%
BADD_D01253Lenalidomide0.011001%
BADD_D01257Letrozole0.000642%
BADD_D01281Levonorgestrel0.035437%
BADD_D01834Prednisone0.000040%
BADD_D02165Teriflunomide0.001737%
BADD_D02170Testosterone0.002078%
BADD_D02236Tofacitinib--
BADD_D02331Valsartan0.000695%
BADD_D02365Vismodegib0.000533%
BADD_D02464Fingolimod0.017370%
The 1th Page    1    Total 1 Pages